Servier Going-Private Day One Biopharmaceuticals Tender

Servier Detroit Inc., a wholly owned subsidiary of Servier Pharmaceuticals LLC and an indirect wholly owned subsidiary of Servier S.A.S., filed Amendment No. 2 to its Schedule TO for a going-private tender offer for all outstanding shares of Day One Biopharmaceuticals, Inc. The filing relates to the offer for Day One common stock (par value $0.0001 per share; CUSIP 23954D109).

The amendment updates Item 11 Additional Information, including revised language in the Offer to Purchase section on antitrust compliance under the HSR Act. The Schedule TO was originally filed March 26, 2026.